Literature DB >> 7545531

Substance-P-mediated intestinal inflammation: inhibitory effects of CP 96,345 and SMS 201-995.

G Kataeva1, A Agro, A M Stanisz.   

Abstract

The proinflammatory peptide substance P (SP) has been shown to be intimately involved in the local inflammatory processes of Trichinella-spiralis-induced murine intestinal inflammation. Significant increases in SP, increased myeloperoxidase levels coupled with local morphological deterioration of the jejunum and impaired lymphocyte responses to exogenous SP in vitro have been associated with the model. We have recently determined that the elimination of increased levels of SP via anti-SP antibody therapy can spare the murine gastrointestinal tract much of the pathologies associated with the parasitic infection. Here we further demonstrate that the somatostatin analogue SMS 201-995 as well as the SP receptor antagonist CP 96,345 can effectively decrease the inflammation and lost lymphocyte function seen in the jejunum of T. spiralis-infected mice. Again, both intestinal morphology and myeloperoxidase levels were shown to return to normal values upon treatment. The above results suggest that SP is an important modulator of gastrointestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7545531     DOI: 10.1159/000097187

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  9 in total

Review 1.  Neuropeptides in lower urinary tract function.

Authors:  Lauren Arms; Margaret A Vizzard
Journal:  Handb Exp Pharmacol       Date:  2011

2.  Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation.

Authors:  T Goode; J O'Connell; P Anton; H Wong; J Reeve; G C O'Sullivan; J K Collins; F Shanahan
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

3.  TGF-beta regulates T-cell neurokinin-1 receptor internalization and function.

Authors:  Martin Beinborn; Arthur Blum; Long Hang; Tommy Setiawan; Jonathan C Schroeder; Korynn Stoyanoff; John Leung; Joel V Weinstock
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

4.  Substance P Exacerbates the Inflammatory and Pro-osteoclastogenic Responses of Murine Osteoclasts and Osteoblasts to Staphylococcus aureus.

Authors:  M Brittany Johnson; Samantha R Suptela; Sophie E Sipprell; Ian Marriott
Journal:  Inflammation       Date:  2022-08-30       Impact factor: 4.657

5.  Somatostatin in inflammatory bowel disease.

Authors:  J D van Bergeijk; J H Wilson
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

Review 6.  Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.

Authors:  Magdy El-Salhy; Tefera Solomon; Trygve Hausken; Odd Helge Gilja; Jan Gunnar Hatlebakk
Journal:  World J Gastroenterol       Date:  2017-07-28       Impact factor: 5.742

Review 7.  The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders.

Authors:  M Brittany Johnson; Ada D Young; Ian Marriott
Journal:  Front Cell Neurosci       Date:  2017-01-04       Impact factor: 5.505

Review 8.  The Neuroimmune Interplay in Joint Pain: The Role of Macrophages.

Authors:  Daniela P Vasconcelos; Clive Jabangwe; Meriem Lamghari; Cecília J Alves
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

Review 9.  Gastrointestinal Parasites and the Neural Control of Gut Functions.

Authors:  Marie C M Halliez; André G Buret
Journal:  Front Cell Neurosci       Date:  2015-11-25       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.